Fed Circuit rejects Minerva patent invalidation bid

Hologic patent invented by Minerva’s founder cannot be invalidated | Patent in dispute concerns device used to treat uterine bleeding | US Court of Appeals.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

Could everyday hospital equipment be the next defence against counterfeit medicines?

23 February 2026 A new study suggests the equipment already found in hospitals worldwide could offer a front line against fake vaccines and insulin.

Medtech

Danaher moves to acquire Masimo in $9.9bn deal

18 February 2026 The science and technology conglomerate’s big diagnostics bet comes with monitoring technology, an AI-powered product pipeline, and a litigation history that has kept Silicon Valley’s biggest player on the back foot.

Medtech

Chinese invisible braces maker hits back at infringement claims

22 August 2025 The company has dismissed recent patent infringement claims from the Invisalign maker as “frivolous and entirely without merit,” pledging a vigorous defence.

More features

Could everyday hospital equipment be the next defence against counterfeit medicines?

BioNTech fires shots at Moderna's next-generation vaccine

Mintz gains ex-Winston & Strawn partner and ITC expert

Abbott unit defends European protection for heart valve ‘cuff’ design

Natera targets ex-employee over mass file download before rival move

Hogan Lovells makes senior public and administrative hire in Italy

Danaher moves to acquire Masimo in $9.9bn deal

Generic rival blocked as AZ defends diabetes stronghold

Fed Circuit rejects Minerva patent invalidation bid

More on this story

Editor's picks

Editor's picks

More features